Skip to content

Drug interactions

Ivacaftor + Orphenadrin

Severity: Minor

Ivacaftor and Orphenadrin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ivacaftor is a CYP3A4 substrate, but orphenadrine is not an established clinically relevant CYP3A4 inhibitor. Any increase in ivacaftor exposure is likely small.

What this interaction means in plain words

Ivacaftor and Orphenadrin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ivacaftor belongs to Miscellaneous; Orphenadrin belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition; not clearly established.

What to do

No routine dose change is needed; monitor for ivacaftor adverse effects such as elevated liver enzymes and headache.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ivacaftor and Orphenadrin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ivacaftor with Orphenadrin?

MediHelp rates the interaction as minor. Ivacaftor and Orphenadrin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ivacaftor is a CYP3A4 substrate, but orphenadrine is not an established clinically relevant CYP3A4 inhibitor. Any increase in ivacaftor exposure is likely small.

How serious is the interaction between Ivacaftor and Orphenadrin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed; monitor for ivacaftor adverse effects such as elevated liver enzymes and headache.

What other medicines interact with Orphenadrin?

MediHelp also lists interactions of Orphenadrin with, for example, Alfentanil, Amobarbital, Benzhydrocodone / acetaminophen. The full list is on the Orphenadrin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in